Goldman Sachs’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Sell |
580,364
-12,884
| -2% | -$27.6K | ﹤0.01% | 3710 |
|
|
2025
Q1 | $682K | Sell |
593,248
-917,509
| -61% | -$1.06M | ﹤0.01% | 4071 |
|
|
2024
Q4 | $3.31M | Sell |
1,510,757
-424,273
| -22% | -$929K | ﹤0.01% | 3158 |
|
|
2024
Q3 | $4.22M | Buy |
1,935,030
+475,899
| +33% | +$1.04M | ﹤0.01% | 2871 |
|
|
2024
Q2 | $3.37M | Sell |
1,459,131
-224,957
| -13% | -$520K | ﹤0.01% | 2889 |
|
|
2024
Q1 | $9.26M | Buy |
1,684,088
+321,299
| +24% | +$1.77M | ﹤0.01% | 2106 |
|
|
2023
Q4 | $3.37M | Sell |
1,362,789
-252,757
| -16% | -$624K | ﹤0.01% | 2866 |
|
|
2023
Q3 | $56.1M | Buy |
1,615,546
+47,726
| +3% | +$1.66M | 0.01% | 873 |
|
|
2023
Q2 | $51.4M | Buy |
1,567,820
+217,280
| +16% | +$7.13M | 0.01% | 922 |
|
|
2023
Q1 | $45.2M | Buy |
1,350,540
+1,304,211
| +2,815% | +$43.7M | 0.01% | 977 |
|
|
2022
Q4 | $1.52M | Buy |
46,329
+22,086
| +91% | +$724K | ﹤0.01% | 3447 |
|
|
2022
Q3 | $846K | Buy |
24,243
+5,375
| +28% | +$188K | ﹤0.01% | 3927 |
|
|
2022
Q2 | $231K | Buy |
+18,868
| New | +$231K | ﹤0.01% | 4835 |
|